Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis

The real-world benefits of direct-acting antiviral (DAA)-induced sustained virologic response (SVR) on the de novo occurrence and progression of esophageal varices (EV) remain unclear in patients with hepatitis C virus (HCV)-related liver cirrhosis (LC). This is a retrospective cohort study evaluati...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Yung-Yu, Chen, Wei-Ming, Chang, Kao-Chi, Chang, Te-Sheng, Hung, Chao-Hung, Yang, Yao-Hsu, Tung, Shui-Yi, Wei, Kuo-Liang, Shen, Chen-Heng, Wu, Cheng-Shyong, Ding, Yuan-Jie, Hu, Jing-Hong, Huang, Yu-Ting, Lin, Meng-Hung, Lu, Chung-Kuang, Lin, Yi-Hsiung, Lin, Ming-Shyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860555/
https://www.ncbi.nlm.nih.gov/pubmed/36680293
http://dx.doi.org/10.3390/v15010252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860555/
https://www.ncbi.nlm.nih.gov/pubmed/36680293
http://dx.doi.org/10.3390/v15010252

Ejemplares similares